Ascelia Pharma (ACE SS)

Analysis

Health Care • Sweden

Ascelia Pharma AB operates as a drug development company. The Company develops medicines and drugs for the treatment of liver metastases and gastric cancer. Ascelia Pharma serves patients in Sweden.

Refresh

Focused

No publications yet

Add Ascelia Pharma to your Watchlist to get alerts on new publications

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00